Fractyl Health, Inc. (GUTS) vs iBio, Inc. (IBIO)
Fractyl Health, Inc. and iBio, Inc. are both Biotechnology companies. Fractyl Health, Inc. and iBio, Inc. are of similar size ($77.3M and $76.4M). Fractyl Health, Inc. grew revenue faster over the last twelve months: −22.5% against −66.6%. Across the 12 metrics below, iBio, Inc. leads on 8 and Fractyl Health, Inc. on 4.
Valuation
Profitability
| Metric | GUTS | IBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 46.24% | 100.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 1,063.04% | (65.70%) | (57.72%) |
| Return on assets | (146.75%) | (54.04%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack